RFL - NYSE

Rafael Holdings, Inc.

RFL·NYSE

$1.39

+7.0%

Real EstateReal Estate - Services

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$51.12M

EPS-1.0400

P/E Ratio-1.34

Earnings Date06/10/2026

114.11M

Assets

18%

3Y-4.0%

5Y-16.0%

10Y+77.0%

15.74M

Total Liabilities

49%

3Y-25.0%

5Y+170.0%

10Y+2.0%

98.37M

Total Equity

14%

3Y+1.0%

5Y-25.0%

10Y+102.0%

Rafael Holdings, Inc. Funding & Solvency Profile

RFL · NYSE

Current Assets

Cash & Cash Equivalents52.77M

Net Receivables1.83M

Inventory281.00K

Other Current Assets786.00K

Total Current Assets57 M

Non-Current Assets

Property, Plant & Equipment1.60M

Goodwill & Intangible Assets52.51M

Long-Term Investments1.86M

Other Non-Current Assets1.43M

Total Non-Current Assets5 M

Total Assets

114.11M

Financial Health Analysis

Current Ratio

4.89x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.16x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

45 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

50% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Rafael Holdings, Inc. Balance Sheet

RFL • NYSE

Rafael Holdings, Inc. Balance Sheet	Jul 2025	Jul 2024	Jul 2023	Jul 2022	Jul 2021	Jul 2020	Jul 2019	Jul 2018	Jul 2017	Jul 2016
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	52.8M	2.7M	21.5M	26.5M	7.9M	6.2M	12M	15.8M	11.8M	2.3M
Short-Term Investments	0.0	63.3M	58M	36.7M	0.0	0.0	0.0	24.7M	0.0	0.0
Cash & Short-Term Investments	52.8M	65.9M	79.5M	63.2M	7.9M	6.2M	12M	40.5M	11.8M	2.3M
Net Receivables	1.8M	6.1M	2.5M	297K	835K	396K	730K	3.6M	264K	257K
Accounts Receivables	627K	426K	213K	157K	235K	396K	730K	3.6M	264K	257K
Other Receivables	1.2M	5.7M	2.3M	140K	600K	0.0	0.0	0.0	0.0	0.0
Inventory	281K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Prepaids	1M	0.0	0.0	0.0	1.1M	0.0	507K	421K	147K	0.0
Other Current Assets	786K	430K	914K	44.8M	5M	3.2M	0.0	0.0	0.0	17K
Total Current Assets	56.7M	72.5M	82.9M	108.3M	14.8M	9.8M	13.3M	44.5M	12.2M	2.6M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.6M	2.1M	1.7M	1.8M	1.8M	44.4M	48.7M	50.1M	51.2M	51M
Goodwill	19.9M	3.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	32.6M	1.8M	1.6M	1.6M	1.6M	1.6M	1.6M	1.7M	0.0	0.0
Goodwill & Intangible Assets	52.5M	4.9M	1.6M	1.6M	1.6M	1.6M	1.6M	1.7M	0.0	0.0
Long-Term Investments	1.9M	12M	7.6M	477K	80.2M	80.4M	72M	15.3M	13.5M	2.1M
Tax Assets	0.0	0.0	5M	0.0	0.0	6K	19K	4.2M	8.9M	8.6M
Other Non-Current Assets	1.4M	5.3M	9K	6.2M	55.7M	80K	6.5M	1.1M	540K	59K
Total Non-Current Assets	57.4M	24.3M	15.9M	10M	139.3M	126.5M	128.9M	72.4M	74M	61.7M
Total Assets	114.1M	96.8M	98.8M	118.3M	154.1M	136.3M	142.1M	116.9M	86.2M	64.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	6.9M	3.3M	333K	564K	1.3M	921K	795K	367K	115K	64K
Accounts Payable	6.9M	2.6M	333K	564K	1.2M	921K	795K	367K	115K	64K
Other Payables	0.0	733K	0.0	0.0	136K	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	814K	1.8M	763K	1.9M	1.2M	0.0	605K	500K	213K	214K
Short Term Debt	614K	2.3M	0.0	15M	14.5M	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8.4M	0.0	0.0
Other Current Liabilities	3.3M	113K	1M	3.6M	252K	4.8M	27K	24K	35K	-278K
Total Current Liabilities	11.6M	7.5M	2.1M	21M	17.3M	5.7M	1.4M	891K	363K	302K
NON-CURRENT LIABILITIES
Long Term Debt	78K	73K	0.0	0.0	0.0	0.0	14.9M	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	138K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	3.9M	3M	55K	88K	48K	92K	1M	464K	23.8M	15.2M
Total Non-Current Liabilities	4.1M	3.1M	55K	88K	48K	92K	16M	464K	23.8M	15.2M
Total Liabilities	15.7M	10.6M	2.2M	21.1M	17.4M	5.8M	17.4M	1.4M	24.1M	15.5M
SHAREHOLDERS' EQUITY
Treasury Stock	-168K	-168K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	516K	246K	244K	245K	177K	157K	139K	126K	50.4M	48.6M
Additional Paid-In Capital	322.2M	280M	264M	262M	159.1M	129.1M	112.9M	103.6M	0.0	0.0
Retained Earnings	-232.3M	-201.7M	-167.3M	-165.5M	-40.8M	-16.3M	-5.8M	-1.1M	0.0	0.0
Accumulated Other Comprehensive Income/Loss	4.1M	111K	3.4M	3.7M	3.8M	3.8M	3.8M	4M	2.3M	189K
Other Total Stockholders' Equity	0.0	3.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	94.4M	82.2M	100.3M	100.5M	122.3M	116.8M	111M	106.7M	52.7M	48.8M
Total Equity	98.4M	86.3M	96.6M	97.2M	136.7M	130.5M	124.8M	115.6M	62.1M	48.8M
Minority Interest	4M	4.1M	-3.7M	-3.3M	14.4M	13.7M	13.8M	8.9M	9.3M	0.0
SUMMARY
Total Liabilities & Equity	114.1M	96.8M	98.8M	118.3M	154.1M	136.3M	142.1M	116.9M	86.2M	64.3M
Total Investments	1.9M	75.3M	65.6M	37.2M	80.2M	80.4M	72M	40M	13.5M	2.1M
Total Debt	692K	2.4M	0.0	15M	14.5M	0.0	14.9M	0.0	0.0	0.0
Net Debt	-52.1M	-288K	-21.5M	-11.5M	6.7M	-6.2M	2.9M	-15.8M	-11.8M	-2.3M
Shares Outstanding	35,093,432	35,093,432	35,093,432	35,093,432	35,093,432	35,093,432	35,093,432	35,093,432	35,093,432	35,093,432

SEC Filings

RFL - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	April 22, 2026	April 22, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 16, 2026	March 16, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	March 16, 2026	January 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 08, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	December 12, 2025	October 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 11, 2025	December 11, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 02, 2025	December 02, 2025	2025	View Filing
DEF 14A DEF 14A 2026 N/A	November 18, 2025	January 08, 2026	2026	View Filing
10-K 10-K 2025 FY FY	October 29, 2025	July 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 29, 2025	October 29, 2025	2025	View Filing

Showing 1 to 10 of 175 filings

Related Guides

Blog Categories

Continue your RFL research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.